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ABSTRACT: Multicellular tumor spheroids (MTS) are a well-established model system for drug development and are a valuable in vitro 
research tool for use prior to employing animal models. These 3D-cell cultures are thought to display chemical gradients of oxygen and 
nutrients throughout their structure, giving rise to distinct microenvironments in radial layers, thus mimicking the pathophysiological envi-
ronment of a tumor. Little is known about the localized distributions of metabolites within these microenvironments. To address this, here 
we utilize high spectral resolution Fourier-transform ion cyclotron resonance (FT-ICR), MALDI mass spectrometry imaging (MSI) to image 
the distribution of endogenous metabolites in breast cancer MCF-7 spheroids. We show that known specific metabolite markers (adenosine 
phosphates and glutathione) indicate that the central region of these cell culture models experiences increased hypoxic and oxidative stress. 
By using discriminatory analysis, we have identified which m/z values localize towards the outer proliferative or central hypoxic regions of 
an MTS and have assigned elemental formula with sub-ppm error. Using this information, we have mapped these metabolites back to distinct 
pathways to improve our understanding of the molecular environment and biochemistry of these tumor models. 
 
Introduction 
Conventionally, adherent mammalian cells are cultured in mono-
layers under carefully controlled conditions  to produce a homoge-
nous population that offers simple and effective experimental con-
sistency.1 These 2-dimensional (2D) cell cultures are indispensable 
model systems utilized in a wide range of basic and clinical in vitro 
studies.  However, despite its widespread use, 2D cell culture fails 
to capture the multifaceted physiology of the in vivo tissue micro-
environment, which is composed of numerous complex structures 
and intricate relationships.2 3-dimensional (3D) cell culture com-
bines the experimental simplicity of monolayer culture whilst re-
taining many of the complex morphological structures of a tissue.3 
Multicellular tumor spheroids (MTS) are spherical self-assembled 
aggregates that, above a critical size, display gradients of oxygen, 
nutrients and metabolite waste similar to those found in tumors. 
Thus, mature MTS display a zoned structure containing a central 
hypoxic region, surrounded by a layer of quiescent cells and an 
outer rim of rapidly proliferating cells.4,5 
A number of analytical techniques have been used to elucidate the 
biology of these structures, such as Raman spectroscopy;6 as well 
as several proteomic studies - including 2D polyacrylamide gel 
electrophoresis (PAGE)7 followed by liquid chromatography mass 
spectrometry (LC-MS),8 and  stable isotope labelling of amino ac-
ids in cell culture (SILAC).9  However, these analyses often rely on 
bulk assays on large numbers of MTS and thus disregard any het-
erogeneity present within spheroids. Therefore, the capacity to 
study a single MTS enables the identification of spatial variation 
within a spheroid caused by zonation.8 Single spheroid studies are 
possible through serial trypsinization and subsequent MS of each 
spheroid layer,10 and imaging techniques such as confocal Raman 
microscopy11 and mass spectrometry imaging (MSI),5 which offer 
the potential to observe spatial distributions of molecules that play 
an important role in cancer metabolism. Extensive sample prepara-
tion and handling affects the composition and detection of metabo-
lites; so MSI offers the advantage of capturing the metabolite dis-
tributions with minimal sample processing.12–14 
Matrix-assisted laser desorption/ionization (MALDI) MSI com-
bines the principles of conventional MALDI-MS with spatial reso-
lution, enabling broad spectral and label-free analysis to discern the 
distribution of ionizable compounds without requiring significant 
preceding knowledge.12,15–17 MSI was first applied to study MTS in 
2011 to observe the distribution of proteins within individual hu-
man carcinoma (HCT 116) spheroids.5 Li and co-workers found 
that cytochrome C and histone H4 distributed uniformly across the 
spheroid and confirmed the identities of these proteins with 
nanoLC-MS/MS. Since this first report, several other studies have 
applied MSI to investigate MTS in a spatially-resolved manner. 
These include observing the distribution of lipids,18 and the time-
dependent penetration of drugs.10,19–21 
However, despite the recent advances in MSI of spheroids, the ma-
jority of the work has been carried out using time-of-flight (ToF) 
MS.22 Whilst ToF-MS instruments provide high sensitivity and rel-
atively fast acquisition of MSI data, they typically have a mass re-
solving power up to 50,000.23 As a result, these instruments lack 
the resolving power and mass accuracy required for definitive de-
termination of elemental formula from accurate m/z measurements. 
In contrast, the high mass resolution and accuracy of Fourier-trans-
form ion cyclotron resonance (FT-ICR) MS enables confident as-
signment of elemental formula,24 and FT-ICR MS is widely used 
for characterization of unknown metabolites.25,26 In an imaging 
workflow, FT-ICR MS enables the simultaneous distribution of 
known metabolites to be visualized without employing MS/MS 
techniques.27  
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Here, we combine the high spectral resolution available using the 
12T FT-ICR (Bruker, Bremen, Germany) with spatial resolution 
imaging at 50 µm for the untargeted analysis of metabolites within 
MCF-7 spheroids. We show that metabolite markers indicate re-
gions of increased hypoxia and oxidative stress within spheroids 
and we use discriminatory analysis to identify metabolites that col-
ocalize to these areas. Finally, we demonstrate that this approach 
can be used to investigate the regional flux through specific bio-
chemical pathways. 
Materials and Methods 
Cell culture and spheroids preparation. MCF-7 cells were do-
nated at passage 52 from the Queen’s Medical Research Institute 
(QMRI), Edinburgh (UK). Both monolayer cells and spheroids 
were grown in Dulbecco’s Modified Eagles Medium (DMEM) 
(Thermo-Fisher, Massachusetts, USA) supplemented with 10% fe-
tal calf serum (FCS) (Sigma Aldrich, Missouri, USA) and 1% pen-
icillin (Thermo-Fisher, Massachusetts, USA). Monolayer cells 
were routinely seeded every 4 days in 75 cm3 flasks with 1 mL cells 
and 9 mL fresh media. The media was replaced every 48 hours. 
Spheroids were obtained using the hanging drop method.6 Approx-
imately 6000 cells were seeded into 20 µL droplets that were then 
suspended from the lid of a petri dish. A reservoir of 10 mL media 
was placed in the bottom of the dish. Spheroids were fed with 5 µL 
fresh media every 48 hours. Spheroids were incubated at 36.5 °C, 
5% CO2 and 95% humidity for 8 days before imaging.  
MALDI imaging sample preparation 
Preparation of spheroids. 8-day-old untreated MCF-7 spheroids 
were prepared using the following method. Media was removed, 
and spheroids were washed with ammonium formate (20 µL, 50 
mM). Each spheroid was picked up using a 20 µL pipette and 
placed into a droplet from which the maximum amount of liquid 
was removed. To aid spheroid detection during sectioning, blue 
dyed gelatin (40 µL, 10% w/v) was placed onto the spheroids and 
frozen on isopentane and dry ice (2 minutes). The gelatin blocks 
were then snap frozen in liquid nitrogen and stored (-80 °C) until 
sectioning. Sectioning was performed using a Leica CM 1900 cry-
ostat at -21 oC (Leica Biosystems, Nussloch, Germany). Sections 
(15 µm) were cut and thaw mounted onto conductive indium tin-
oxide (ITO)-coated glass slides (Bruker Daltonics, Bremen, Ger-
many). Consecutive sections were taken for haematoxylin and eo-
sin (H&E) staining. An optimized converted 3D printer28 was used 
to apply 8 coats of 9-aminoacridine (9AA) matrix (10 mg/mL, 70% 
ACN), at a flow rate of 0.1 mL/minute at 40 °C with a gas pressure 
of 50 psi, a z height of 30 mm and velocity of 1100 mm/minute. 
These parameters resulted in a matrix density of 0.11 mg/cm2. 
H&E Staining. Sectioned spheroids were placed onto a glass slide 
and stored in a vacuum desiccator (room temperature, 18h). Sec-
tions were covered with haematoxylin (Sigma-Aldrich, Missouri, 
USA) (3 minutes) and washed with running water. The slide was 
coated with tap water (1 minute), then acid alcohol (Sigma-Aldrich, 
Missouri, USA) (20 seconds) and then washed using water. Eosin 
(Sigma-Aldrich, Missouri, USA) was added (1 minute) and then 
washed with water. The stained cells were then air dried before be-
ing imaged under the 40x objective on an inverted AE2000 (Motic, 
Hong Kong) microscope.  Experiments were repeated for six bio-
logical replicates. 
MALDI Mass Spectrometry Imaging. For this study, all mass 
spectrometry experiments were performed on a 12T SolariX FT-
ICR MS equipped with an infinity ICR cell and a MALDI ioniza-
tion using a SmartBeam II UV laser (Bruker Daltonics, Bremen, 
Germany) in negative ion mode using 9AA matrix. An m/z range 
of 98-1500 was acquired in broadband mode with a data acquisition 
time per pixel of 2 MWord. The laser raster increment was set to 
40 µm along both the x and y axis with a smart walk of 50 µm. 
Laser focus was set to minimum (15 µm), with a frequency of 1000 
Hz. Ions were accumulated across 300 laser shots for each mass 
analysis. Calibration of the spheroid data was performed post-pro-
cessing by exporting pixels from FlexImaging 4.1 into DataAnaly-
sis 4.4 and calibrated using a pre-determined list of internal cali-
brants (supporting information Table S1). The images were then 
analyzed with total ion count (TIC) normalization using SCiLS 
software version 2019a (Bruker Daltonics, Bremen, Germany).  Ion 
maps were generated with a semiquantitative color scale bar nor-
malized to the TIC. The mass resolution at m/z 300 was ca. 100000. 
Discriminatory analysis. The spheroids were segregated into the 
‘outer’ and ‘central’ regions based on 50% of the radius. For auto-
matically finding m/z values discriminating the outer and central 
regions, the receiver operating characteristic (ROC) tool was em-
ployed and the area under the ROC curve (AUC value) was calcu-
lated (SCiLS, Bruker Daltonics). A threshold was set for the top 
five discriminatory m/z values. Using a representative pixel from 
either region, the calibrated m/z values were then assigned formulae 
using Human Metabolome Database (HMDB) 
http://www.hmdb.ca/spectra/ms/search with an error tolerance of 1 
ppm for the [M-H]- ion. The distributions of identified discrimina-
tory metabolites were verified manually with at least six biological 
replicates. For comparison of the ion abundances of individual spe-
cies between regions of spheroids, ion abundance distributions 
were represented as box and whisker plots using SCiLS software.  
Results and Discussion 
Cell culture and spheroids preparation. This study was per-
formed with MCF-7 3D cell cultures grown over 8 days to form 
spheroids of approximately 500 µm in diameter. To prepare the 
samples, the spheroids were embedded in gelatin and sections were 
taken close to the hemisphere of individual spheroids. Before MS 
analysis, H&E staining was used to confirm the structural integrity 
of the sections (see Figure 1A and supporting information Figure 
S1). Spheroid sections were then coated in matrix and subject to 
MALDI FT-ICR MS. 
Initial high mass resolution MSI analysis across MTS. When 
MTS are grown to diameters above 200 µm, they are known to dis-
play gradients of oxygen, nutrients and waste products, producing 
a hypoxic environment in the central core.6 In order to visualize the 
distribution of metabolites across these gradients, we employed a 
MALDI MSI workflow with high resolution FT-ICR MS. Spheroid 
sections were imaged in negative-ion mode using 9AA matrix at 50 
µm spatial resolution between m/z 98-1500. For this experimental 
set-up, the dwell time per pixel was 1000-1500 ms, which resulted 
in a total data acquisition time of ca. 20 minutes per spheroid sec-
tion. 9AA was used as a matrix as it is effective in ionizing small 
molecular weight metabolites including nucleotides and phos-
phates, which are important in understanding the biology of cancer.  
As discussed above, the principal advantage of high spectral reso-
lution MSI is the ability to assign elemental formulae from accurate 
m/z measurements. Thus in an imaging experiment, where the spa-
tial distribution of hundreds to thousands of metabolites are 
mapped simultaneously, high mass resolution allows assignment of 
these without the requirement for targeted MS/MS approaches.25 
Figure 1 highlights the differences in the profile mass spectra pro-
duced from areas across the diameter of the spheroid (in this case, 
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the central and outer regions). By inspection of an exported repre-
sentative pixel from the outer and centre region, it is clear that spec-
tra from the spheroid are highly complex, and significant differ-
ences in the profile mass spectra are apparent in two regions (Figure 
1A). Across the entire spectrum, formulae were assigned to each 
peak with sub-ppm error and database searches offered tentative 
metabolite identifications.  A narrow region of each spectrum is 
shown in Figure 1B, highlighting the variation in abundance of spe-
cies between the outer and centre region of the spheroid. The inten-
sity of these peaks is consistent across the spheroid as shown by the 
ion density maps (Figure 1C). 
 
 
Figure 1. (A) A representative H&E stained section of the MCF-7 
spheroids used in this study. A FT-ICR mass spectrum from a rep-
resentative pixel in the outer and centre regions of the MCF-7 sphe-
roid is shown. (B) Representative pixels from the (top) outer and 
(bottom) centre region of an MCF-7 spheroid imaged at 50 µm res-
olution. Using HMDB, each peak could be assigned with sub-ppm 
error and the relative intensity compared between the regions. The 
errors identified were 0.0719, 0.3816, 0.2375 and 0.1174 ppm for 
each assigned formula respectively. (C) The ion density maps for 
each of the formula assigned are displayed.  
MS imaging highlights redox and energy gradients across 
MTS. During MSI, the signal abundance of an ion irradiated from 
any point is assumed to be proportional to the concentration of the 
targeted analyte. However this view is over simplistic, as the ana-
lytes present in different areas of a sample could be ionized to var-
ying extents as a result of ion suppression and sample prepara-
tion.29,30 Alternatively, the proportional abundance of individual 
ions can be used to compare how their ratios change in different 
locations across the tissue.31 Using this approach, we can use a tar-
geted method and compare the distributions of known metabolites 
within MTS (supporting information, Table S2). Initially we chose 
to analyze the distributions of oxidized/reduced glutathione and 
high energy adenosine phosphates as these are thought to be af-
fected by the nutrient and oxygen gradients within MTS.32  
 
An increased distribution of adenosine triphosphate (ATP) in the 
outer region of the spheroid indicates a decreasing oxygen gradient 
through the spheroid. Almost every cellular process requires en-
ergy, converting ATP to adenosine diphosphate (ADP) and phos-
phate. As a result, one of the fundamental parameters that all living 
cells must maintain is a high ratio of ATP to ADP. At equilibrium, 
the ratio for ATP:ADP under intracellular conditions is around 10-
7:1. However, living cells maintain this ratio around 10:1; 108 or-
ders of magnitude away from equilibrium.33 This ratio is a central 
control parameter of intracellular energy metabolism that deter-
mines the free-energy change for ATP hydrolysis and therefore the 
driving force for many reactions.34 For example, in glucose metab-
olism, the ATP:ADP ratio determines whether the reaction flux 
through phosphoglycerate kinase is in the glycolytic or gluconeo-
genic direction.34 If mitochondrial ATP synthesis becomes com-
promised when the cell is under stress, such as during hypoxia, the 
ATP:ADP ratio drops dramatically. This results in stimulation of 
glycolysis to generate ATP anaerobically. The ATP yield per mole 
of glucose is much lower for glycolysis compared to mitochondrial 
oxidative phosphorylation (2 moles of ATP vs. ~35 moles of ATP 
per mole of glucose, respectively).35 Interestingly, the total 
ATP:ADP ratio in spheroids is thought to be reduced compared to 
monolayer cell culture.36 Furthermore, as spheroids age and in-
crease in size, the rate of glycolysis increases.36 This suggests that 
whilst monolayer and small spheroids rely primarily on oxidative 
phosphorylation for energy production, larger spheroid’s energy 
demand is predominantly supported by the glycolytic pathway.36 
As a result, the ability to observe changes in the ATP:ADP ratio 
can be used to visualize energy changes in cells.37 
Ions corresponding to ATP, ADP and AMP are all observed in our 
MSI data of MCF-7 spheroids, and all three biomolecules display 
consistent gradients across multiple separately imaged spheroids 
(supporting information, Figure S2). Importantly, the high spectral 
resolution obtainable by FT-ICR enables the observation of iso-
topic fine structure (IFS) of the first isotope peak for ATP, ADP 
and AMP (i.e. the mass discrepancy between 13C and 15N) to in-
crease the confidence of the formula assignment (supporting infor-
mation, Figure S3). The distributions of the [M-H]- m/z value of 
ATP (m/z 505.9885) localized distinctly towards the outer region 
of the MCF-7 spheroid with 0.140 ppm error (Figure 2). In contrast, 
ADP (m/z 426.0221) and adenosine monophosphate (AMP) (m/z 
346.0558) are more uniformly localized across the spheroid with 
0.167 and 0.179 ppm errors respectively. The observed ratio of ion 
abundance for ATP and ADP shows that, although ADP has a 
higher abundance in both the outer and centre of the spheroid, there 
is a marked decrease in the ATP:ADP ion ratio in the center (Figure 
2C). This observation suggests that that there is a lower rate of ATP 
production relative to dephosphorylation in this central region of 
the spheroid, and the cellular environment is energy depleted, and 
potentially hypoxic compared to the outer region of the spheroid. 
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C12H22O14S 
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Figure 2. (A) Ion density map of ATP, ADP and AMP across an 
MCF-7 spheroid imaged at 50 µm resolution using the FT-ICR MSI 
and 9AA matrix application. (B) Box and whisker plot showing the 
intensity of the peak for each pixel in the allocated outer and centre 
regions. 
An increased ratio of glutathione disulfide to glutathione is indica-
tive of hypoxic environment in the central region of the spheroid. 
The tripeptide glutathione (GSH) plays an important role in main-
taining the cellular redox homeostasis through oxidation of its 
sulfhydryl group to form glutathione disulfide (GSSG).38 The over-
all concentration of GSH varies between organisms, however it ex-
ists in vivo predominantly in the reduced form to maintain the 
GSH:GSSG ratio and avert oxidative stress and apoptosis.39 Under 
oxidative stress GSH is oxidized, resulting in an intracellular redox 
imbalance reflected by a decreased GSH:GSSG ratio.40 Thus the 
ratio of GSH:GSSG has been proposed to be a marker for the oxi-
dative nature of the cellular environment and a potential indicator 
of oxidative stress.  
The distributions of the [M-H]- m/z values of GSSG (m/z 611.1447) 
and GSH (m/z 306.0765) were imaged within the MCF-7 spheroid 
with 0.294 ppm and 0.289 ppm errors respectively (Figure 3). 
Overall, both GSSG and GSH increase in intensity towards the cen-
tre of the spheroid (Figure 3A). However, the observed ratio of ion 
abundance for the GSH:GSSG ions differs in the two regions and a 
clear decrease in this ratio was observed in the inner region. (Figure 
3B). This observation was consistent across biological replicates 
(supporting information, Figures S4 and S5) and the average 
GSH:GSSG abundance ratios were determined to be 1.01 (=0.31) 
and 0.78 (=0.08) for the outer and central regions respectively 
(N=6). These findings suggest that the oxidized form is present in 
a higher relative abundance compared to the reduced form in the 
central region of the spheroid, consistent with greater oxidative 
stress experienced in this central region. 
 
Figure 3. (A) Ion density map of oxidized (m/z 611.1447) and re-
duced (m/z 306.0765) glutathione with overlaid spectra showing 
with 0.294 ppm and 0.289 ppm errors respectively. (B) The box 
and whisker plots correspond to the intensity of the m/z value for 
each pixel allocated to the outer and center region. Note that the 
intensity of the oxidized form is greater relative to the reduced form 
in the center region.
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Figure 4. Discriminatory analysis for the identified five outer discriminatory molecules. Formula were assigned with a sub-ppm error and 
their ion density map, box and whisker plot of the intensities are shown for each formula identified. GlcNAc-1-P N-acetyl glucosamine-1-
phosphate; UMP uridine monophosphate; UDP uridine diphosphate; UTP uridine triphosphate; UDP-GlcNAc uridine diphosphate-N-acetyl 
glucosamine . 
Discriminatory analysis was performed to identify metabolites that 
are affected most by the hypoxia-induced oxidative stress produced 
across the spheroid’s diameter. For this analysis, two regions were 
defined within a spheroid as the ‘outer’ and ‘center’ based on 50 % 
of the radius (supporting information, Figure S6). For each m/z 
value the area under the receiver operating characteristic curve 
(AUC of ROC) was determined and the top five discriminatory me-
tabolites in each region were tentatively identified based on their 
m/z using HMDB. More detailed information for each analysis is 
available in the supporting information (supporting information, 
Tables S3 and S4). 
High energy uridine phosphates are localized to areas of high 
oxygen availability. The five molecules that discriminated most 
strongly towards the outer region were identified using the HMDB 
with a sub-1 ppm error (Figure 4). Remarkably, all five of the dis-
criminatory molecules were identified as uridine phosphates based 
on their m/z and isotopic fine structure. This is in agreement with 
recent findings that hypoxia is associated with decreased abun-
dance of uridine nucleosides.41,42  
In our data, uridine triphosphate (UTP) (AUC = 0.960), uridine di-
phosphate (UDP) (AUC = 0.992) and UDP-N-acetyl hexose iso-
mers, such as UDP-N-acetylglucosamine (UDP-GlcNAc) (AUC = 
0.887) display gradients across the diameter of a spheroid. These 
distributions were reproducible across multiple biological repli-
cates (supporting information, Figure S7) These metabolites play 
central roles in the hexosamine biosynthetic pathway (HBP), from 
which the high energy end product UDP-GlcNAc is catabolized 
from glucose, glutamine, acetyl-CoA and UTP.43 Subsequently, 
UDP-GlcNAc plays an important role in proliferation by contrib-
uting to the synthesis of glycosaminoglycans, proteoglycans, and 
glycolipids that regulate cell signalling and enzyme activity in pri-
mary metabolism.44,45 
It is thought that under conditions of energetic surplus, up to 10% 
of glycolytic flux can be redirected into the HBP to produce UDP-
GlcNAc. In contrast, insufficient oxygen inhibits the HBP and re-
directs glucose through glycolysis to produce ATP as an energy 
source.46,47 This is supported by our findings that in the central hy-
poxic region of the spheroid there are marked decreased levels of 
HBP intermediates. In addition, we also observed upregulation of 
assigned glycolysis intermediates in the centre of the spheroid. This 
included C6H13O9P (m/z 259.0224) corresponding to hexose-mono-
phosphates (e.g. glucose-6-phosphate (G-6-P), galactose-6-phos-
phate and fructose-6-phosphate (F-6-P)) and fructose-1,6-bisphos-
phate (F-1,6-BisP) (m/z 338.9888) (Figure 5). The cleavage of F-
1,6-BisP during the next steps of glycolysis produces dihydroxy-
acetone phosphate (DHAP) and glycerol-3-phosphate, whose dis-
tributions were not observed. 
 
Figure 5. The elemental formula of the metabolites assigned can be 
mapped onto the hexosamine biosynthetic pathway (HBP). Note 
how the HBP is upregulated in the outer region, whereas glycolysis 
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intermediates are upregulated in the centre region. Glucosamine-6-
P was not observed. 
High energy cytidine phosphates localize in areas of low oxygen 
availability. The five molecules that discriminated most strongly 
towards the centre region were also identified using the HMDB 
with sub-1 ppm error. Four of these are related metabolites and all 
contain cytidine, including cytidine diphosphate (CDP) (AUC = 
0.967), cytidine monophosphate (CMP) (AUC = 0.978), CDP- eth-
anolamine (AUC = 0.979), and cytidine-2’, 3’-cyclic phosphate 
(AUC = 0.950) (Figure 6). These distributions were reproducible 
across 6 biological replicates (supporting information, Figure S8). 
Cytidine and uridine have a mass difference of 0.9840 Da, (UDP: 
[M-H]- m/z 323.02859; CDP: [M-H]-  m/z 322.0446). Therefore, we 
note that the high spectral resolution offered by FT-ICR allows the 
resolution of the monoisotopic peak of UDP to the first isotope of 
CDP with ease (Supporting information, Figure S9).  
High-energy cytidine phosphates are utilized in the post-
translational modification of glycoproteins and glycosylation of 
glycolipids with N-acetylneuraminic acid (NeuNAc), the end-
product of the sialic acid pathway (Figure 7). Interestingly, there is 
evidence that cancer cells present elevated levels of neuraminic 
acid which has been suggested to play an important role in 
malignancy and the evasion of the immune system.45 Furthermore, 
it is thought that hypoxia further increases the expression of 
intracellular NeuNAc.48  
 
 
Figure 6.  Discriminatory analysis for the identified five centre discriminatory molecules. Formula were assigned with a sub-ppm error and 
their ion density map (top), and box and whisker plot (bottom) are shown for each formula identified. G-6-P Gluocse-6-phosphate ; cCMP 
cytidine-2’3’- cyclic phosphate; CMP cytidine monophosphate; CDP cytidine diphosphate; F-1-P), CDP-Etn cytidine diphosphate ethano-
lamine. 
 
 
In addition, the sialic acid pathway and the HBP are closely linked, 
whereby NeuNAc can be converted to CMP-NeuNAc for use in the 
sialic pathway, or alternatively isomerized to N-
acetylmannosamine (ManNAc) which can be converted back into 
GlcNAc and salvaged back into the HBP (Figure 7).47 As shown in 
our data, the intermediates of both these pathways have distinct 
distributions in the MTS. As discussed above, high energy uridine 
phosphates associated with the HBP are localized towards the outer 
proliferative regions (Figure 5). In contrast, high energy cytidine 
phosphates distribute towards the oxidative hypoxic conditions of 
the central region (Figure 7). These distibutions suggest that the 
microenvironments within MTS display distinct metabolic fluxes 
in these pathways. 
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Figure 7. Sialic acid pathway. N-acetyl neuraminic acid (sialic 
acid) is formed by the end product of the hexosamine pathway 
(HBP). UDP-GlcNAc Uridine N-acetylglucosamine; UDP Uridine 
diphosphate; ATP adenosine triphosphate; ADP; adenosine 
diphosphate; ManNAc-6-P N-acetylmannosamine-6-phosphate; 
Neu9NAc-9-P N-acetylneuraminic acid-9-phosphate; NeuNAc N-
acetylneuraminic acid; CMP-NeuAc cytidine monophosphate N-
acetylneuraminic acid; CMP cytidine monophosphate. 
 
In the context of cancer biology, the requirement for high energy 
co-substrates during the synthesis of both CMP-NeuNAc and UDP-
GlcNAc as part of glycan production suggests that cancer cells 
have effective coping mechanisms for maintaining surface 
sialylation under nutrient deprivation. These metabolic flux-driven 
changes could contribute to the propensity of a tumor to adapt its 
metabolism to different environments. 
 
Conclusions 
Here we have shown the application of high resolution MSI to 
determine metabolite distributions within MTS cell culture models. 
We show that metabolite markers can be used to indicate regions 
of increased oxidative stress and hypoxia. In addition, we highlight 
that the information obtained using this approach may be 
informative for investigating the regional flux through biochemical 
pathways. We have shown that there is upregulation of metabolic 
branch pathways such as the HBP in the regions of the spheroid 
with greater access to oxygen. Conversely, there is greater 
glycolytic flux within the regions limited by hypoxia. However, the 
presence of ionization bias enables the comparison of relative 
intensities, but prevents any definitive quantification of the 
distributions observed Whilst MSI using FT-ICR provides 
unparalleled spectral resolution allowing confident elemental 
assignment, the acquisition time is inherently slow as the high mass 
resolving power requires long transients to be acquired for each 
pixel.23 By increasing the transient recording time, FT-ICR pro-
duces an approximately linear improvement for mass resolution.49 
However, given that a typical MS image can consist of tens of thou-
sands of pixels, acquisition time may become a constraining factor. 
Thus there is in effect a trade-off between spectral resolution and 
data aquisition time.. However, in comparison to animal tissue 
samples, the small size of MTS mitigates this disadvantage 
somewhat, allowing multiple biological replicates to be analyzed 
on realistic timescales. Therefore, this methodology shows great 
promise for applications in toxicity studies during drug 
development, whereby the absorption, distribution and metabolism 
of the drug could be correlated with its effects on cellular 
metabolism.  
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teristic; AUC, area under the ROC curve; ATP, adenosine triphos-
phate; ADP, adenosine diphosphate; AMP, adenosine monophos-
phate; GSH, glutathione; GSSG, glutathione disulfide; ROS, of re-
active oxygen species; HIF-1α, hypoxia-inducible factor; UTP, ur-
idine triphosphate; UDP, uridine diphosphate; GlcNAc, N-acetyl-
glucosamine; UDP-GlcNAc, UDP-N-acetylglucosamine; HBP, 
hexosamine biosynthetic pathway; G-6-P, glucose-6-phosphate; F-
6-P, fructose-6-phosphate;  F-1,6-BisP, fructose-1,6-bisphosphate; 
DHAP, dihydroxyacetone phosphate; CDP, cytidine diphosphate; 
CMP, cytidine monophosphate; CDP-Etn, CDP- ethanolamine; 
cCMP, cytidine-2’, 3’-cyclic phosphate; NeuNAc, N-acetylneu-
raminic acid; ManNAc, N-acetylmannosamine; DESI, desorption 
electrospray. 
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